EVH
Evolent Health Inc
NYSE: EVH · HEALTHCARE · HEALTH INFORMATION SERVICES
$4.33
-2.04% today
Updated 2026-10-28
Market cap
$550.60M
P/E ratio
—
P/S ratio
0.26x
EPS (TTM)
$-4.49
Dividend yield
—
52W range
$2 – $8
Volume
2.2M
Evolent Health Inc (EVH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.33
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.9B | $1.4B | $2.0B | $2.6B | $1.9B | $2.2B | $2.5B | $2.9B | $3.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 15.20% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -24.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.